BEATRIZ
ARRIZABALAGA AMUCHASTEGUI
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (30)
2021
-
Prediction of liver iron overload in the Basque country (Spain) in patients referred for hyperferritinemia
Digestive and Liver Disease
2020
-
Autoimmune haemolytic anaemias: A retrospective study of 93 patients
Medicina Clinica, Vol. 154, Núm. 9, pp. 331-337
-
Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients
Pharmacogenomics Journal, Vol. 20, Núm. 5, pp. 664-671
-
Liver iron concentration in dysmetabolic hyperferritinemia: Results from a prospective cohort of 276 patients
Annals of Hepatology, Vol. 19, Núm. 1, pp. 31-35
-
Luspatercept in patients with lower-risk myelodysplastic syndromes
New England Journal of Medicine, Vol. 382, Núm. 2, pp. 140-151
-
Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies
Journal of Medical Genetics, Vol. 57, Núm. 4, pp. 258-268
-
miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk
Leukemia, Vol. 34, Núm. 10, pp. 2648-2659
2017
-
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group
Leukemia Research, Vol. 63, pp. 85-89
-
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R)
American Journal of Hematology, Vol. 92, Núm. 7, pp. 614-621
-
Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload
Clinical Biochemistry, Vol. 50, Núm. 16-17, pp. 911-917
-
Phenotype of mutations in the promoter region of the β-globin gene
Journal of Clinical Pathology, Vol. 70, Núm. 10, pp. 874-878
-
Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry
Annals of Hematology, Vol. 96, Núm. 10, pp. 1727-1733
2016
-
Considering bone marrow blasts from nonerythroid cellularity improves the prognostic evaluation of myelodysplastic syndromes
Journal of Clinical Oncology, Vol. 34, Núm. 27, pp. 3284-3292
-
Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing
International Journal of Laboratory Hematology, Vol. 38, Núm. 6, pp. 629-638
-
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: A rationale for its inclusion into future classifications of myelodysplastic syndromes
Modern Pathology, Vol. 29, Núm. 12, pp. 1541-1551
-
Hereditary xerocytosis, a misleading anemia
Annals of Hematology
-
Severe neonatal jaundice due to a de novo glucose-6-phosphate dehydrogenase deficient mutation
International Journal of Laboratory Hematology
-
Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria
Medicina Clinica
2015
-
Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
Annals of Hematology, Vol. 94, Núm. 5, pp. 779-787
-
Trisomy 8, a cytogenetic abnormality in myelodysplastic syndromes, is constitutional or not?
PLoS ONE, Vol. 10, Núm. 6